摘要 : This phase I study was conducted to determine the maximum tolerated dose (MTD) and dose limiting toxicities (DLTs) of the heat shock protein 90 (HSP90) inhibitor 17-allyamino-17-demethoxygeldanamycin (17-AAG) in combination with b... 展开
作者 | Walker~A.R. Klisovic~R. Johnston~J.S. Jiang~Y. Geyer~S. Kefauver~C. Binkley~P. Byrd~J.C. Grever~M.R. Garzon~R. Phelps~M.A. Marcucci~G. Blum~K.A. Blum~W. |
---|---|
作者单位 | |
期刊名称 | 《Leukemia and lymphoma》 |
总页数 | 7 |
语种/中图分类号 | 英语 / R73 |
关键词 | 17-AAG Bortezomib Heat shock protein inhibition Relapsed AML |
馆藏号 | N2007EPST0000973 |